O A Gansow - JoVE Visualize

Showing results (11-20 of 60) with videos related to

Pageof 6

Sort By:

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989

Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenograftsM Roselli, J Schlom, O A Gansow, et al.

Nuclear Medicine and Biology|April 1, 1995

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodiesT K Nikula, M J Curcio, M W Brechbiel, et al.

Cancer Research|July 15, 1990

Improved in vivo stability and tumor targeting of bismuth-labeled antibodyC L Ruegg, W T Anderson-Berg, M W Brechbiel, et al.

Cancer Research|October 15, 1992

Effective alpha-particle-mediated radioimmunotherapy of murine leukemiaR B Huneke, C G Pippin, R A Squire, et al.

Nuclear Medicine and Biology|February 19, 1998

Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targetsU P Schwarz, P Plascjak, M P Beitzel, et al.

Journal of Medicinal Chemistry|August 28, 1998

Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugatesT J McMurry, C G Pippin, C Wu, et al.

Cancer Research|December 1, 1993

Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapyR P Junghans, D Dobbs, M W Brechbiel, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 1, 1986

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapyR W Kozak, R W Atcher, O A Gansow, et al.

Magnetic Resonance Imaging|January 1, 1995

Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivoF N Franano, W B Edwards, M J Welch, et al.

Bioconjugate Chemistry|July 1, 1992

An improved method for labeling monoclonal antibodies with samarium-153: use of the bifunctional chelate 2-(p-isothiocyanatobenzyl)-6- methyldiethylenetriaminepentaacetic acidM E Izard, G R Boniface, K L Hardiman, et al.

Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:

Pageof 6

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989

Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenograftsM Roselli, J Schlom, O A Gansow, et al.

Nuclear Medicine and Biology|April 1, 1995

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodiesT K Nikula, M J Curcio, M W Brechbiel, et al.

Cancer Research|July 15, 1990

Improved in vivo stability and tumor targeting of bismuth-labeled antibodyC L Ruegg, W T Anderson-Berg, M W Brechbiel, et al.

Cancer Research|October 15, 1992

Effective alpha-particle-mediated radioimmunotherapy of murine leukemiaR B Huneke, C G Pippin, R A Squire, et al.

Nuclear Medicine and Biology|February 19, 1998

Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targetsU P Schwarz, P Plascjak, M P Beitzel, et al.

Journal of Medicinal Chemistry|August 28, 1998

Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugatesT J McMurry, C G Pippin, C Wu, et al.

Cancer Research|December 1, 1993

Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapyR P Junghans, D Dobbs, M W Brechbiel, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 1, 1986

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapyR W Kozak, R W Atcher, O A Gansow, et al.

Magnetic Resonance Imaging|January 1, 1995

Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivoF N Franano, W B Edwards, M J Welch, et al.

Bioconjugate Chemistry|July 1, 1992

An improved method for labeling monoclonal antibodies with samarium-153: use of the bifunctional chelate 2-(p-isothiocyanatobenzyl)-6- methyldiethylenetriaminepentaacetic acidM E Izard, G R Boniface, K L Hardiman, et al.

Pageof 6